Street Calls of the Week
Saba Capital Management, L.P., along with Boaz Weinstein, reported selling 14,083 shares of abrdn Life Sciences Investors NASDAQ:HQL common stock on September 2, 2025. The shares were sold at a price of $14.04, for a total transaction value of $197725. The stock, currently trading at $14.06, offers an impressive 11.9% dividend yield and has posted a strong 19% return year-to-date. According to InvestingPro, HQL has maintained dividend payments for 30 consecutive years.
Following the transaction, Saba Capital Management, L.P. still owns 2968623 shares of abrdn Life Sciences Investors, representing a significant position in the $406 million market cap company. InvestingPro subscribers can access 4 additional key insights about HQL’s financial health and valuation metrics.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.